Search

Search bills, members, committees and pages...

GENENTECH, INC.

105 federal lobbying filings, 2023 to 2026.

GENENTECH, INC. is a client on 105 federal lobbying filings, 2023 to 2026, reporting $5.5M across them. pharmaceutical and biotechnology company Based in District of Columbia.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

8 it has hired, by filings.

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
202616$840K
202530$1.6M
202429$1.5M
202330$1.6M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues68
MMMMedicare/Medicaid35
BUDBudget/Appropriations30
PHAPharmacy29
CPTCopyright/Patent/Trademark16
TAXTaxation/Internal Revenue Code15
TRDTrade (domestic/foreign)14

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…6
H.Con.Res. 14Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…3
S. 1040Drug Competition Enhancement Act3
S. 1041Affordable Prescriptions for Patients Act3
S.Con.Res. 7An original concurrent resolution setting forth the congressional budget for the United States Government for…3
H.R. 3269ETHIC Act2
H.R. 7148Consolidated Appropriations Act, 20262
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.1
H.R. 2882Central Coast of California Conservation Act of 20251

Lobbyists

Named on the filings.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
GENENTECH, INC.HARBINGER STRATEGIES, LLC2026 second_quarter$60KJul 21, 2026
GENENTECH, INC.TODD STRATEGY GROUP2026 second_quarter$60KJul 21, 2026
GENENTECH, INC.KING & SPALDING LLP2026 second_quarter$20KJul 20, 2026
GENENTECH, INC.TARPLIN, DOWNS & YOUNG, LLC2026 second_quarter$60KJul 20, 2026
GENENTECH, INC.YC CONSULTING, LLC2026 second_quarter$50KJul 20, 2026
GENENTECH, INC.TIBER CREEK HEALTH STRATEGIES, INC.2026 second_quarter$60KJul 19, 2026
GENENTECH, INC.MARSHALL & POPP, LLC2026 second_quarter$60KJul 9, 2026
GENENTECH, INC.CORNERSTONE GOVERNMENT AFFAIRS, INC.2026 second_quarter$50KJul 8, 2026
GENENTECH, INC.KING & SPALDING LLP2026 first_quarter$20KApr 21, 2026
GENENTECH, INC.HARBINGER STRATEGIES, LLC2026 first_quarter$60KApr 21, 2026
GENENTECH, INC.TODD STRATEGY GROUP2026 first_quarter$60KApr 20, 2026
GENENTECH, INC.TARPLIN, DOWNS & YOUNG, LLC2026 first_quarter$60KApr 20, 2026
GENENTECH, INC.YC CONSULTING, LLC2026 first_quarter$50KApr 20, 2026
GENENTECH, INC.TIBER CREEK HEALTH STRATEGIES, INC.2026 first_quarter$60KApr 18, 2026
GENENTECH, INC.MARSHALL & POPP, LLC2026 first_quarter$60KApr 17, 2026
GENENTECH, INC.CORNERSTONE GOVERNMENT AFFAIRS, INC.2026 first_quarter$50KApr 7, 2026
GENENTECH, INC.YC CONSULTING, LLC2025 fourth_quarter$30KJan 21, 2026
GENENTECH, INC.TODD STRATEGY GROUP2025 fourth_quarter$60KJan 21, 2026
GENENTECH, INC.HARBINGER STRATEGIES, LLC2025 fourth_quarter$50KJan 21, 2026
GENENTECH, INC.TARPLIN, DOWNS & YOUNG, LLC2025 fourth_quarter$60KJan 20, 2026
GENENTECH, INC.KING & SPALDING LLP2025 fourth_quarter$20KJan 20, 2026
GENENTECH, INC.TIBER CREEK HEALTH STRATEGIES, INC.2025 fourth_quarter$60KJan 20, 2026
GENENTECH, INC.MARSHALL & POPP, LLC2025 fourth_quarter$60KJan 16, 2026
GENENTECH, INC.CORNERSTONE GOVERNMENT AFFAIRS, INC.2025 fourth_quarter$50KJan 16, 2026
GENENTECH, INC.YC CONSULTING, LLC2025 fourth_quarterNov 5, 2025